The MAPRx Coalition appreciates the opportunity to provide the Centers for Medicare & Medicaid Services (CMS) with comments regarding Medicare Part D plan sponsor data reporting requirements, as requested in the notice published in the Federal Register on February 2, 2024.
Highlights include:
• Part D plan...
MAPRx urges Congress and CMS to establish comprehensive obesity coverage in Medicare Part D through a one pager.
Highlights include:
• Treat and Reduce Obesity Act: Bipartisan, bicameral legislation to establish anti-obesity medication coverage through Medicare Part D
• CMS Guidance: to establish AOM coverage thorough revised Part...
Earlier today the MAPRx Coalition submitted comments to the Centers for Medicare & Medicaid Services (CMS) regarding the memorandum Medicare Prescription Payment Plan: Draft Part Two Guidance on Select Topics, Implementation of Section 1860D-2 of the Social Security Act for 2025, published on February 15, 2024.
Earlier today the MAPRx Coalition released the Issue Brief: Minimizing Affordability Challenges and Beneficiary Confusion. Linked HERE.
Highlights of the Issue Brief:
The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2023 – December 7, 2023 for coverage beginning January 1, 2024. Plans make changes to benefits and costs, and there are also new plans in many areas of the country. Changes to the Part D benefit as a whole...
Earlier today, the MAPRx Coalition submitted comments to the Centers for Medicare & Medicaid Services (CMS) regarding the implementation of the Medicare Prescription Payment Plan program set to take effect for Contract Year (CY) 2025 per the Memorandum Maximum Monthly Cap on Cost-Sharing Payments Under Prescription Drug Plans: Draft Part One Guidance on...
Earlier today, the MAPRx Coalition submitted to the Centers for Medicare & Medicaid Services (CMS) comments regarding the implementation of the Medicare Drug Price Negotiation Program (MDPNP) for initial price applicability year 2026.
The Coalition appreciates the opportunity to comment on how Medicare intends to negotiate with
pharmaceutical manufacturers for lower...
The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2022 – December 7, 2022 for coverage beginning January 1, 2023. Plans make changes to benefits and costs, and there are also new plans in many areas of the country. Changes to the Part D benefit as a whole...
A new report commissioned by the MAPRx Coalition examines the growing clinical evidence for coverage of anti-obesity medications (AOMs) approved by the Food and Drug Administration in Medicare Part D.
As the medical community’s understanding of disease states evolves, MAPRx is calling on the Part D program to evolve...
Earlier today, the MAPRx Coalition and 35 member organizations submitted a letter to Senate leadership ahead of their continued consideration of the Inflation Reduction Act of 2022 via the Senate's reconciliation process.
While members of the Coalition have differing views on other components of the expansive package, the Coalition and...
No comments by MAPRx yet.